INBS (Intelligent Bio Solutions Inc. Common Stock) Stock Analysis

Intelligent Bio Solutions Inc. Common Stock (INBS) is a publicly traded Healthcare sector company. As of May 21, 2026, INBS trades at $2.90 with a market cap of $8.73M and a P/E ratio of 0.34. INBS moved -11.85% today. Year to date, INBS is -74.27%; over the trailing twelve months it is -77.89%. Its 52-week range spans $2.27 to $27.50. Rallies surfaces INBS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the latest INBS stock research?

Intelligent Bio Solutions Inc. Common Stock (INBS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INBS moved -11.85% today.

INBS Key Metrics

Key financial metrics for INBS
MetricValue
Price$2.90
Market Cap$8.73M
P/E Ratio0.34
EPS$8.95
Dividend Yield0.00%
52-Week High$27.50
52-Week Low$2.27
Volume169.68K
Avg Volume0
Revenue (TTM)$3.91M
Net Income$-11.65M
Gross Margin47.25%

Latest INBS News

Recent INBS Insider Trades

  • Simeonidis Harry bought 50 (~$92.5) on Sep 1, 2023.
  • Simeonidis Harry bought 100 (~$192) on Aug 31, 2023.

INBS Analyst Consensus

INBS analyst coverage data. Average price target: $0.00.

Common questions about INBS

What can I research for INBS on Rallies?
Intelligent Bio Solutions Inc. Common Stock (INBS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INBS moved -11.85% today.
Does Rallies show live market data for INBS?
Rallies combines live market context with ticker research for INBS, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
INBS

INBS